Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients.
Autor: | Nadler, Jeffrey P.1 jnadler@hsc.usf.edu, Gathe, Joseph C.2 drgathe@josephgathe.com, Pollard, Richard B.3 rbpollard@ucdavis.edu, Richmond, Gary J.4 garyrichmond@earthlink.net, Qiming Liao5 Qiming.M.Liao@gsk.com, Griffith, Sandy5 Sandy.K.Griffith@gsk.com, Lancaster, C. Tracey5 Charles.T.Lancaster@gsk.com, Hernandez, Jaime E.5 Jaime.E.Hernandez@gsk.com, Pappa, Keith A.5 Keith.A.Pappa@gsk.com |
---|---|
Zdroj: | BMC Infectious Diseases. 2003, Vol. 3 Issue 1, p10-9. 9p. 2 Charts, 3 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |